---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-001074"
form_type: "8-K"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2025-01-06T23:59:59+00:00"
generated_at: "2026-05-28T10:47:26.206036+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics reduces authorized common shares to 100M via charter amendment

## Summary
- Filed Certificate of Amendment decreasing authorized common stock to 100 million shares (par value $0.0001).
- Authorized preferred stock unchanged at 10 million shares (par value $0.0001).
- Amendment effective upon filing on December 30, 2024.
- No other changes to the Amended and Restated Certificate of Incorporation.

## SEC filing metadata
- accession: 0001493152-25-001074
- form_type: 8-K
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2025-01-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315225001074/0001493152-25-001074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315225001074/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-001074
- JSON: https://secwatch.observer/filing/0001493152-25-001074.json
- Plain text: https://secwatch.observer/filing/0001493152-25-001074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.